Allosteric Modulators of Muscarinic Acetylcholine Receptors as a Novel Approach for Treatment of Schizophrenia

Psychiatry Grand Rounds

Tuesday, November 29, 2022 at 11:00 AM


Grand Round starts in:

Online Streaming
November 29th, 2022
1.00 AMA PRA Category 1 Credit Hours

Description

Understanding muscarinic receptor activators for schizophrenia treatment

Dates and Times

Start: 11/29/2022 11:00 AM
End: 11/29/2022 12:00 PM

Objectives

1.  Understand the potential utility of muscarinic receptor activators for treatment of schizophrenia.

2.  Understand the different mechanisms of action by which activators of M1 and M4 subtypes of muscaric receptors may provide efficacy in treatment of different symptoms of schizophrenia.

3.  Understand the unique properties of positive allosteric modulators of muscarinic receptors that make them suitable as potential therapeutic agents.

Grand Round Files

File Link

RefsNov29DrConnGranRounds

Dr. Jeffrey Conn references for Nov. 29, 2022, Psychiatry Grand Rounds

Download

Speakers

  • Dr. Jeffrey Conn
    • Understanding muscarinic receptor activators for schizophrenia treatment

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Need help with this Grand Round Session?

Please contact the Grand Round coordinator listed below:

Mary Carlson
Department: Psychiatry
Phone: (631) 444-2767
Email: Mary.carlson@stonybrookmedicine.edu

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222